Ingvil Mjaaland

2.6k total citations
43 papers, 1.6k citations indexed

About

Ingvil Mjaaland is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ingvil Mjaaland has authored 43 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 20 papers in Cancer Research and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ingvil Mjaaland's work include Breast Cancer Treatment Studies (19 papers), Cancer Treatment and Pharmacology (7 papers) and Advanced Radiotherapy Techniques (7 papers). Ingvil Mjaaland is often cited by papers focused on Breast Cancer Treatment Studies (19 papers), Cancer Treatment and Pharmacology (7 papers) and Advanced Radiotherapy Techniques (7 papers). Ingvil Mjaaland collaborates with scholars based in Norway, Denmark and Sweden. Ingvil Mjaaland's co-authors include Johan Vikström, Mari H. B. Hjelstuen, Bjørn Østenstad, Carl Blomqvist, Vahur Valvere, Nils‐Olof Bengtsson, Jonas Bergh, Terje Risberg, J Sjöström and Erik Løkkevik and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Ingvil Mjaaland

42 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ingvil Mjaaland Norway 20 885 822 371 369 302 43 1.6k
Lars Stenbygaard Denmark 12 657 0.7× 516 0.6× 177 0.5× 305 0.8× 240 0.8× 29 1.1k
Samuele Massarut Italy 21 558 0.6× 794 1.0× 442 1.2× 238 0.6× 292 1.0× 67 1.5k
Lior Z. Braunstein United States 20 488 0.6× 739 0.9× 133 0.4× 273 0.7× 481 1.6× 99 1.6k
Gillian C. Barnett United Kingdom 22 535 0.6× 684 0.8× 545 1.5× 728 2.0× 465 1.5× 41 2.1k
K.I. Pritchard Canada 15 682 0.8× 580 0.7× 55 0.1× 184 0.5× 182 0.6× 35 1.1k
Aurélie Bertaut France 24 838 0.9× 291 0.4× 122 0.3× 590 1.6× 357 1.2× 105 1.8k
Edgar Ben‐Josef United States 19 408 0.5× 176 0.2× 256 0.7× 973 2.6× 324 1.1× 34 1.6k
Frances Duane United Kingdom 15 384 0.4× 935 1.1× 658 1.8× 554 1.5× 89 0.3× 39 1.7k
Sofía Rivera France 16 277 0.3× 261 0.3× 174 0.5× 247 0.7× 134 0.4× 89 842
Kathy Han Canada 22 865 1.0× 343 0.4× 363 1.0× 459 1.2× 772 2.6× 102 2.7k

Countries citing papers authored by Ingvil Mjaaland

Since Specialization
Citations

This map shows the geographic impact of Ingvil Mjaaland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingvil Mjaaland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingvil Mjaaland more than expected).

Fields of papers citing papers by Ingvil Mjaaland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingvil Mjaaland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingvil Mjaaland. The network helps show where Ingvil Mjaaland may publish in the future.

Co-authorship network of co-authors of Ingvil Mjaaland

This figure shows the co-authorship network connecting the top 25 collaborators of Ingvil Mjaaland. A scholar is included among the top collaborators of Ingvil Mjaaland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingvil Mjaaland. Ingvil Mjaaland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Boersma, Liesbeth, Ingvil Mjaaland, & Frederieke van Duijnhoven. (2023). Regional radiotherapy after primary systemic treatment for cN+ breast cancer patients. The Breast. 68. 181–188. 4 indexed citations
2.
3.
Benstead, Kim, Pedro C. Lara, Lotte Engell-Noerregaard, et al.. (2020). Clinical oncology module for the ESTRO core curriculum. Radiotherapy and Oncology. 156. 19–22. 6 indexed citations
4.
5.
Vikström, Johan, et al.. (2018). A comparison of conventional and dynamic radiotherapy planning techniques for early-stage breast cancer utilizing deep inspiration breath-hold. Acta Oncologica. 57(10). 1325–1330. 19 indexed citations
6.
Francolini, Giulio, Mette S. Thomsen, Esben Svitzer Yates, et al.. (2017). Quality assessment of delineation and dose planning of early breast cancer patients included in the randomized Skagen Trial 1. Radiotherapy and Oncology. 123(2). 282–287. 13 indexed citations
7.
Offersen, B.V., Morten Holtegaard Nielsen, Martín Krause, et al.. (2017). Hypo- vs normofractionated radiation therapy of early stage breast cancer in the randomized DBCG HYPO trial. European Journal of Cancer. 72. S9–S10. 1 indexed citations
8.
Cameron, Marte Grønlie, Christian Kersten, Ingvild Vistad, et al.. (2015). Palliative pelvic radiotherapy for symptomatic incurable prostate cancer – A prospective multicenter study. Radiotherapy and Oncology. 115(3). 314–320. 15 indexed citations
9.
Hjelstuen, Mari H. B., et al.. (2014). Pulmonary function tests – an easy selection method for respiratory-gated radiotherapy in patients with left-sided breast cancer. Acta Oncologica. 54(7). 1025–1031. 5 indexed citations
10.
Synnestvedt, Marit, Elin Borgen, Erik Wist, et al.. (2012). Disseminated tumor cells as selection marker and monitoring tool for secondary adjuvant treatment in early breast cancer. Descriptive results from an intervention study. BMC Cancer. 12(1). 616–616. 18 indexed citations
11.
Chrisanthar, Ranjan, Stian Knappskog, Erik Løkkevik, et al.. (2011). Predictive and Prognostic Impact of TP53 Mutations and MDM2 Promoter Genotype in Primary Breast Cancer Patients Treated with Epirubicin or Paclitaxel. PLoS ONE. 6(4). e19249–e19249. 81 indexed citations
12.
Mjaaland, Ingvil, et al.. (2010). Residiv og overlevelse etter brystbevarende behandling av brystkreft. Tidsskrift for Den norske legeforening. 130(4). 370–374. 1 indexed citations
13.
14.
Boguslawski, Kristina von, et al.. (2009). The expression of p53, bcl-2, bax, fas and fasL in the primary tumour and lymph node metastases of breast cancer. Acta Oncologica. 48(8). 1137–1143. 19 indexed citations
15.
Mjaaland, Ingvil, et al.. (2003). Strålebehandling etter brystbevarende kirurgi. Tidsskrift for Den Norske Laegeforening. 1 indexed citations
16.
Sjöström, J, Juhani Collan, Kristina von Boguslawski, et al.. (2002). C-erbB-2 expression does not predict response to docetaxel or sequential methotrexate and 5-fluorouracil in advanced breast cancer. European Journal of Cancer. 38(4). 535–542. 36 indexed citations
17.
Luoma, Minna‐Liisa, Liisa Hakamies‐Blomqvist, Johanna Sjöström, et al.. (2002). Physical Performance, Toxicity, and Quality of Life as Assessed by the Physician and the Patient. Acta Oncologica. 41(1). 44–49. 13 indexed citations
18.
Hakamies‐Blomqvist, Liisa, Minna‐Liisa Luoma, J Sjöström, et al.. (2001). Timing of quality of life (QoL) assessments as a source of error in oncological trials. Journal of Advanced Nursing. 35(5). 709–716. 31 indexed citations
19.
20.
Mair, W, et al.. (1986). Polychemotherapie fortgeschrittener Weichteilsarkome mit 4’-Epi-Doxorubicin (4’-Epi-DX) und Cisplatin (DDP). Oncology Research and Treatment. 9(1). 24–28. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lars Stenbygaard Breakdown of academic impact, for papers by Samuele Massarut Breakdown of academic impact, for papers by Lior Z. Braunstein Breakdown of academic impact, for papers by Gillian C. Barnett Breakdown of academic impact, for papers by K.I. Pritchard Breakdown of academic impact, for papers by Aurélie Bertaut Breakdown of academic impact, for papers by Edgar Ben‐Josef Breakdown of academic impact, for papers by Frances Duane Breakdown of academic impact, for papers by Sofía Rivera Breakdown of academic impact, for papers by Kathy Han
Rankless by CCL
2026